PRINT THIS PAGE

Nordic mid-market buy-out firm Segulah sells CCS to C.B. Fleet

Segulah II has sold Clean Chemical Sweden to US pharmaceutical company C.B. Fleet, marking the firm's third exit in the past 12 months. Financial terms of the deal have not been disclosed but Segulah says that this transaction has been one of the biggest and most successful deals in Segulah's ten-year history.

CCS is a supplier of pharmaceutical and non-pharmaceutical body care and eye care products. Segulah II acquired CCS in June 2003 from listed medical research company Medivir.

'There is clear industrial logic in a combination of CCS and C.B. Fleet, a growing international pharmaceuticals company. We are pleased with CCS' development and with our investment,' comments Christian Sievert, managing partner at Segulah.

'The CCS deal is a signal that there is more interest in the Nordic market from US industrial buyers now than there was two or three years ago,' Sievert adds.

Segulah is currently looking to make its first investments from its most recent fund, Segulah III, which was closed in autumn 2004.

Copyright © 2005 AltAssets